7 Tips for Selecting the Best Marketing Automation Software

 Marketing Automation Software is highly advanced software that enables marketing teams to get leads and convert them through the sales funnel. The software also helps analyze buyer behavior, along with detailed data on how the marketing campaign is performing as well as its ROI. The marketing automation software helps in setting automatic workflows that save time and ensures that users engage the required channels. It also gathers all user-related information, converts it into valuable data, and helps design impactful marketing campaigns. Marketing automation software is capable of efficiently engaging users in real-time so that they can be added to the sales funnel. It leverages user data and enables personalized communication to build long-lasting customer relationships. 

Tips To Select Best Marketing Automation Software 

Marketing automation software is available in different types and sizes, as every organization has different requirements. The software that is selected also needs to grow along with the organization, which is challenging. To select the best marketing automation software platform for your organization, you need to consider several factors. Hence, having a checklist handy is always helpful. Given below is a quick checklist that you can go through for selecting the best platform for your organization. 

Is the software powerful? 

For this, it is important to understand the strength of marketing automation software. This can be decided based on the features it offers. These features could be automated emails, social media integration, digitals ads, landing pages, SEO, lead capturing &nurturing, interaction with users, and many others. 

Is the software user-friendly? 

As the software is loaded with features, it is important to understand how easy it is to understand those features and use them. Hence, understanding its ease of use and the training required to use it is an important factor. 

Is the software customizable? 

Every business has different needs for different industries that they work with. Hence, understanding if the software is customizable and if it can create templates and other workflows based on specific tasks is a key factor to consider.

 

Is the software scalable? 

Marketing automation software should grow along with an organization’s growth and needs. Hence, if the platform is scalable, it can easily upgrade itself based on the growing customer base and business segment. 

Does the software support third-party integration? 

Marketing automation software works more efficiently if it is integrated with CRM software. A platform that supports existing systems becomes helpful as it enables multiple teams working on the same project to work collaboratively.  

Is the platform cost-effective? 

Marketing automation software comes at a particular cost that comprises setup charges, training costs, user based charges, service charges, and other such charges based on the vendor. Planning the budget to buy this software becomes helpful as companies can directly pitch for the required software with the planned budget. 

Does the vendor provide after-sales service or customer service? 

Marketing automation software users need constant customer support as the software deals completely with handling clients and potential customers. Thus, choosing a vendor that provides highly skilled technical support to resolve software related problems in real-time will be a good call. 

Checking customer reviews and feedback on the marketing automation software that you plan to purchase will also be very helpful. This will let you understand which software is used by organizations in your industry and could help narrow down your search. 

Suggested Read: Best Marketing Automation Software Vendors 2020 and Benefits 

About 360Quadrants 

360Quadrants is the largest marketplace looking to disrupt USD3.7 trillion of technology spends and is the only rating platform for vendors in the technology space. The platform provides users access to unbiased information that helps them make qualified business decisions. The platform facilitates deeper insight using direct engagement with 650+ industry experts and analysts and allows buyers to discuss their requirements with 7,500 vendors. Companies get to win ideal new customers, customize their quadrants, decide key parameters, and position themselves strategically in a niche space, to be consumed by giants and start-ups alike. Experts get to grow their brand and increase their thought leadership. The platform targets the building of a social network that links industry experts with companies worldwide. The platform has around 400 total buyers across various markets. 

360Quadrants will also be launching quadrants in fields like Email Marketing, Social Media Analytics Software, and Social Media Management Software. 

Contact: 
 Mr. Agney Sugla 
agney@marketsandmarkets.com 
 630 Dundee Road, Suite 430 
 Northbrook, IL 60062 
 USA: +1-888-600-6441 

Medical bed market Analysis as per the Latest COVID-19 Impact

 Factors such as increasing investments in healthcare infrastructural development, technological innovations in ICU beds, increasing number of beds in private hospitals, and increasing volume of chronic care patients are expected to drive the growth of the medical beds market in the coming years.

Medical bed market is expected to reach $3.41 billion by 2022 from $2.59 billion in 2017, at a CAGR of 5.6% during the forecast period.

Medical Bed Market by Usage (Acute Care, Long Term Care, Psychiatric Care, Maternity), Application (Intensive Care, Non Intensive), Type (Electric Beds, Semi Electric Bed, Manual Bed), End User (Hospital, Home Care, Elderly Care) – Global Forecast

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171671404

Global Medical Bed Market is Segmented on:

1. Usage
2. Application
3. Type
4. End User

Type

On the basis of type, the medical beds market is segmented into— manual beds, semi-electric beds, and electric beds. The electric beds segment is expected to dominate the medical beds market in 2017. The growing obesity rate is the major factor driving the demand for electric beds, as these are essential medical equipment in bariatric care.

Usage

Based on usage, the medical beds market is segmented into major four categories— acute care, psychiatric care and bariatric care, long-term care, and other beds (maternity and rehabilitative beds). The long-term care segment is expected to have the fastest-growing market during the forecast period owing to the increasing number of patients requiring long-term care.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=171671404

The geographical regions mapped in the report are:

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Rest of Europe(RoE)
• Asia-Pacific
• Rest of the World (RoW)

Geographical Growth Analysis:

Geographically, Europe is expected to account for the largest share of the global medical beds market in 2017, followed by North America. Compared to mature markets, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period. Growth in this regional segment is propelled by the growing healthcare infrastructure, rising number of contract manufacturing organizations (CMOs), and increasing number of bariatric population requiring care.

Some key players mentioned in the research report are:

The key players in the Medical bed market are Capsugel (US), ACG Worldwide (India), Qualicaps (Japan), Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada)

COVID-19 Impact ON global Empty Capsules market | Country Level Analysis, Current Trade Size And Future Prospective

 The major factors that are expected to be driving the empty capsules market are the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market with the increasing R&D activities & clinical trial studies, and the advancements in capsule delivery technologies. The objective of the report is to define, describe, and forecast the empty capsules market size based on type, functionality, application, end user, and region.

MarketsandMarkets forecasts the Empty Capsules market to grow from USD 1.95 billion in 2018 to USD 2.79 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period.

Empty Capsules Market by Type ((Gelatin – Porcine, Bovine, Bone Meal), (HPMC, Pullulan)), Functionality (Sustained-release, Delayed-release), Application (Antibiotics, Vitamins, Antacids), End User (Pharma, Nutraceuticals, Cosmetics) – Forecast to 2023

To get 10% customization on the report, click @ : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190

Global Empty Capsules Market is Segmented on:

1. Type
2. Functionality
3. Application
4. End User

Type

Among the type of capsules segment, the non-gelatin capsules segment is expected to grow at the highest CAGR during the forecast period. The increasing demand for non-animal-based products and the advantages offered by these capsules over gelatin-based ones, such as low hygroscopicity, physical stability, stability in different ranges of temperature & humidity, and low moisture content are driving the segment growth.

Functionality

The immediate-release capsules segment is expected to witness a faster growth rate in this market, as they are widely used for the manufacture of antibiotics, antibacterials, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements. Also, immediate-release capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert@ : https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=218018190

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific (APAC)
4. Latin America
5. Middle East and Africa (MEA)

Geographical Growth Analysis:

North America is expected to hold the largest market size in the empty capsules market during the forecast period, followed by the European region. The highest market share of North America can be attributed to the existing presence of major capsule manufacturers with large production capacities along with the presence of a number of pharmaceutical giants with large production capacities utilizing these capsules.

Some key players mentioned in the research report are:

• The key players in the Empty Capsules Market are Capsugel (US), ACG Worldwide (India), Qualicaps (Japan), Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada)
• Capsugel is one of crucial players in the empty capsules market, serving over 4,000 customers across 100 countries, through 13 manufacturing sites and three R&D centers. The company is largely known for its diversified product offerings for the pharmaceutical and nutraceutical industry, offering gelatin, vegetarian, filled hard, functional, inhalation, HPMC, gelatin, alternate polymer, specialized clinical, and enteric capsules.

You can Buy This Report from Here @  https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=218018190

Global Healthcare BPO Market | Increasing Consolidation in the Healthcare Industry

 According to the new market research report “Healthcare BPO Market by Outsourcing Approaches, Pharmaceutical (R&D, Manufacturing, Sales and Marketing Services (Performance Reporting, Forecasting)), Provider (Patient Care, RCM), Payer (Claims Repricing), Models (Multisourcing) – Global Forecasts”, , published by MarketsandMarkets™,Healthcare BPO market is estimated to grow at a CAGR of 10.2% from 2017 to 2022 to reach $312.43 billion by 2022 from $191.68 billion in 2017.

Browse in-depth TOC on “Healthcare BPO Market”
156 – Table
34 – Figures
201 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=472

Based on provider services, the Healthcare BPO market is segmented into revenue cycle management, patient enrolment & strategic planning, and patient care. The revenue cycle management segment is expected to grow at the highest CAGR during the forecast period. Growth in the revenue cycle management market can largely be attributed to factors such as decreasing reimbursements in the healthcare industry, reductions in the overall healthcare costs, initiatives undertaken by governments for implementing RCM solutions, and increasing expenditure by the Healthcare IT industry.

Based on payer services, the Healthcare BPO market is segmented into claims management, integrated front-end services and back-office operations, member management, product development & business acquisition, provider management, care management, billing & accounts management services, and HR services. The product development & business acquisition services segment is expected to grow at the highest CAGR during the forecast period.

On the basis of pharmaceutical services, is segmented into manufacturing services, R&D services, and non-clinical services. The non-clinical services segment is expected to account for the highest CAGR during the forecast period. Factors like pricing pressure and the requirement of large field forces have further contributed towards the emergence of contract sales organizations in the pharmaceutical industry.

Request Sample Report : https://www.marketsandmarkets.com/requestsampleNew.asp?id=472

North America to account for the largest market size during the forecast period :

India possesses lucrative growth potential for the healthcare BPO market, by destination geography during the forecast period. Factors like a mature pharmaceutical and medical education system, large English-speaking population, low-cost base, large talent pool, and diverse set of business process outsourcing (BPO) providers, including local and multinational BPO companies, are driving the market in India.

Key Market Players :

The key players in the healthcare BPO market are Cognizant (US), Accenture (Ireland), Xerox (US), Genpact (Bermuda), TCS (India), and Infosys (India). These players focused on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the market.

Global Digital Therapeutic (DTx) Market | Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS)

The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.

The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).

On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, unstable payment models, and resistance from traditional healthcare providers are challenging the growth of this market to a certain extent.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market. There is growing awareness among providers, payers, and employers about the benefits provided by digital therapeutics and the healthcare cost reductions achieved by their use.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724

Global Digital therapeutics market is Segmented on:

1. Type
2. Therapeutic
3. Application

Based on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers. The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period. The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.

Based on the application, the digital therapeutics market is segmented into preventive and treatment/care-related applications. One of the key factors driving the growth of this segment is the rise in treatment and healthcare costs, especially due to chronic conditions. Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724

The geographical regions mapped in the report are:

The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW. In 2019, North America (US and Canada) held the largest share of the market, followed by Europe. The major factors supporting market growth include the increasing investments in digital therapeutics, the influx of new start-ups, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements.

Some key players mentioned in the research report are:

The digital therapeutics market is fragmented in nature, with a large number of players, including tier 1 and mid-tier companies competing for market shares. The prominent players in the global digital therapeutics market include Noom (US), Livongo Health (US), Omada Health (US), WellDoc (US), Pear Therapeutics (US), Proteus Digital Health (US), Propeller Health (US), Akili Interactive Labs (US), Better Therapeutics (US), Happify (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), Wellthy Therapeutics (India), Cognoa (US), Ayogo Health (Canada), Mindstrong Health (US), 2Morrow (US), and Ginger (US

Drug Screening Market (WITH IMPACT OF COVID-19) | Product (Immunoassay Analyzer, Chromatography, Breathalyzer)

According to the new market research report “Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) – Global Forecast ” published by MarketsandMarkets™

Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.

What the Market Looks Like?

The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW).

The global market by sample type is segmented into urine, breath, oral fluid, hair, and other samples. The urine sample segment is estimated to account for the largest share in 2017, however, the oral fluid samples segment is expected to register the highest growth rate during the forecast period.

Get a sample PDF copy of the Report @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

What Drives the Market?

The growth of the global market for Drug Screening Market is primarily influenced by the following factors:

1 Growing Drug & Alcohol Consumption
2 Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
3 Presence of Government Funding in Major Markets
4 Regulatory Approvals & Product Launches and Services

The study involved four major activities to estimate the current market size for particle therapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

The drug screening market is highly competitive with the presence of several big and small players. Prominent players offering products for drug screening include Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). On the other hand, LabCorp (US),etc

Read more about Drug Screening Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

Infectious Disease Diagnostics Market | Technology (Immunodiagnostics, PCR, NGS)

According to the new market research report “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) – Global Forecast to 2022” published by MarketsandMarkets™

The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.

What Drives the Market?

1. Increasing global prevalence of infectious diseases
2. Shift in focus from centralized laboratories to decentralized point-of-care testing
3. Growth in funding for research on infectious disease diagnostics

The global prevalence of infectious diseases such as influenza, HPV, hepatitis, HIV, and tuberculosis is considerably high in spite of significant improvements in sanitation practices and medicine. Many of the currently available diagnostic techniques are slow, involve complex procedures, and lack specific identification of causative agents.

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=116764589

By product and service, assays, kits and reagents segment to record the highest CAGR during the forecast period

Increased accessibility and the increasing number of IDD tests conducted are the key drivers for this segment. Globally, the volume of IDD tests is increasing mainly due to the rising geriatric population; increasing prevalence of infectious diseases; increased variety of reagents available and analytical techniques employed; and the continuous launch of newer, faster, and more reliable products.

Roche, Bio-Rad, and bioMérieux are some of the major players in the infectious disease diagnostics market for assays, kits, & reagents.

On the basis of disease type, the infectious disease diagnostics (IDD) market is segmented into a wide range of diseases. Hospital acquired infections (HAI) segment to record the highest CAGR during the forecast period. Growth in HAI segment can be attributed to the rising burden of MRSA infections, the increasing number of new products launched in the market, and increasing adoption of technologically advanced HAI diagnostic tests such as BD MAX Cdiff assay, Xpert MRSA NxG, and ARIES C. difficile Assay that are based on PCR technology

Early buyers will receive 10% customization on reports – https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=116764589

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

North America accounted for the largest share of the global infectious disease diagnostics market. The large share of this region is mainly attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.

Some key players mentioned in the research report are:

Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific

Critical questions the report answers:

• Where will all these developments take the industry in the long term?
• What are the upcoming trends for the infectious disease diagnostics market?
• Which segment provides the most opportunity for growth?
• Who are the leading vendors operating in this market?
• What are the opportunities for new market entrants?

Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589